These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007419. PubMed ID: 30325017 [TBL] [Abstract][Full Text] [Related]
6. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415 [TBL] [Abstract][Full Text] [Related]
7. The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema. Denniston AK; Chakravarthy U; Zhu H; Lee AY; Crabb DP; Tufail A; Bailey C; Akerele T; Al-Husainy S; Brand C; Downey L; Fitt A; Khan R; Kumar V; Lobo A; Mahmood S; Mandal K; Mckibbin M; Menon G; Natha S; Ong JM; Tsaloumas MD; Varma A; Wilkinson E; Johnston RL; Egan CA; Br J Ophthalmol; 2017 Dec; 101(12):1673-1678. PubMed ID: 28487377 [TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Virgili G; Menchini F; Murro V; Peluso E; Rosa F; Casazza G Cochrane Database Syst Rev; 2011 Jul; (7):CD008081. PubMed ID: 21735421 [TBL] [Abstract][Full Text] [Related]
9. Real-world management of treatment-naïve diabetic macular oedema: 2-year visual outcome focusing on the starting year of intervention Shimura M; Kitano S; Muramatsu D; Fukushima H; Takamura Y; Matsumoto M; Kokado M; Kogo J; Sasaki M; Morizane Y; Utsumi T; Koto T; Sonoda S; Hirano T; Ishikawa H; Mitamura Y; Okamoto F; Kinoshita T; Kimura K; Sugimoto M; Yamashiro K; Suzuki Y; Hikichi T; Washio N; Sato T; Ohkoshi K; Tsujinaka H; Kusuhara S; Kondo M; Takagi H; Murata T; Sakamoto T; Br J Ophthalmol; 2020 Dec; 104(12):1755-1761. PubMed ID: 32169861 [TBL] [Abstract][Full Text] [Related]
10. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. Virgili G; Curran K; Lucenteforte E; Peto T; Parravano M Cochrane Database Syst Rev; 2023 Jun; 2023(6):CD007419. PubMed ID: 38275741 [TBL] [Abstract][Full Text] [Related]
11. Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy. Mikhail M; Stewart S; Seow F; Hogg R; Lois N Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1411-1418. PubMed ID: 29779188 [TBL] [Abstract][Full Text] [Related]
12. Fasting plasma glucose variability is an independent risk factor for diabetic retinopathy and diabetic macular oedema in type 2 diabetes: An 8-year prospective cohort study. Hsieh YT; Hsieh MC Clin Exp Ophthalmol; 2020 May; 48(4):470-476. PubMed ID: 32065699 [TBL] [Abstract][Full Text] [Related]
13. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT. Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393 [TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema. Virgili G; Parravano M; Menchini F; Brunetti M Cochrane Database Syst Rev; 2012 Dec; 12():CD007419. PubMed ID: 23235642 [TBL] [Abstract][Full Text] [Related]